We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TXNM
276
TXNM Energy Inc
TXNM
$5.94B
| $20.7M | 0.11% |
+368,000
| New | +$20M |
|
277
Krystal Biotech
KRYS
$9.25B
| $20.7M | 0.11% |
150,616
-71,427
| -32% | -$10.5M |
|
|
K
278
DELISTED
Kellanova
K
| $20.6M | 0.11% |
259,084
+11,369
| +5% | +$929K |
|
|
SWTX
279
DELISTED
SpringWorks Therapeutics
SWTX
| $20.5M | 0.11% |
437,000
-1,707,814
| -80% | -$76M |
|
280
RTX Corp
RTX
$292B
| $20.5M | 0.11% |
140,532
-503,301
| -78% | -$67.1M |
|
|
MAG
281
DELISTED
MAG Silver
MAG
| $20.4M | 0.11% |
+966,000
| New | +$17.2M |
|
|
CNR
282
Core Natural Resources Inc
CNR
$4.05B
| $20.4M | 0.11% |
+291,881
| New | +$20.8M |
|
283
Cooper Companies
COO
$14.5B
| $20.3M | 0.11% |
285,172
-282,230
| -50% | -$21.6M |
|
284
Crescent Energy
CRGY
$3.77B
| $20.2M | 0.11% |
2,345,044
+1,172,374
| +100% | +$10.3M |
|
285
SM Energy
SM
$7.66B
| $20.1M | 0.11% |
+812,696
| New | +$19.7M |
|
|
B
286
Barrick Mining
B
$62.6B
| $19.8M | 0.1% |
+951,788
| New | +$18.6M |
|
287
Caterpillar
CAT
$382B
| $19.7M | 0.1% |
50,874
+10,496
| +26% | +$3.5M |
|
288
Corebridge Financial
CRBG
$14B
| $19.7M | 0.1% |
556,000
+400,526
| +258% | +$12.5M |
|
289
Verizon
VZ
$197B
| $19.7M | 0.1% |
456,039
-1,528,165
| -77% | -$66.2M |
|
290
Align Technology
ALGN
$12.4B
| $19.7M | 0.1% |
104,028
+43,744
| +73% | +$7.73M |
|
291
W.W. Grainger
GWW
$64.7B
| $19.6M | 0.1% |
18,887
-12,272
| -39% | -$12.8M |
|
292
ACV Auctions
ACVA
$1.36B
| $19.6M | 0.1% |
+1,207,565
| New | +$18.8M |
|
293
Eastman Chemical
EMN
$8.23B
| $19.6M | 0.1% |
262,326
+252,596
| +2,596% | +$19.8M |
|
294
PepsiCo
PEP
$191B
| $19.6M | 0.1% |
148,308
+47,247
| +47% | +$6.36M |
|
|
RAL
295
Ralliant Corp
RAL
$7.21B
| $19.5M | 0.1% |
+402,513
| New | +$19.8M |
|
|
AMRZ
296
Amrize Ltd
AMRZ
$28.3B
| $19.5M | 0.1% |
+393,548
| New | +$19.9M |
|
297
Kyndryl
KD
$3.07B
| $19.5M | 0.1% |
+463,703
| New | +$16.8M |
|
298
Sagimet Biosciences
SGMT
$442M
| $19.5M | 0.1% |
+2,552,536
| New | +$10.8M |
|
299
Hormel Foods
HRL
$13.9B
| $19.4M | 0.1% |
639,716
+615,133
| +2,502% | +$18.6M |
|
300
American Express
AXP
$233B
| $19.1M | 0.1% |
59,868
+12,979
| +28% | +$3.65M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.